Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05916625
Status:
RECRUITING
Last Update Posted:
2023-09-28
First Post:
2023-04-12
Brief Title:
Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinsons Disease
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinsons
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PARK 5-HT4
Brief Summary:
The research aim to study in detail the motor cognitive and affective modifications of Parkinsonian patients compared to control subjects at a moderate stage of the disease and to analyze by positron emission tomography PET imaging with the specific radioligand 11CSB207145 the expression levels of this 5-HT4 receptor At the same time the study will monitor the impact of the 5-HTTLPR polymorphisms of Serotonin Transporter SERT and Brain-derived neurotrophic factor BDNF Val66Met on the expression of the 5-HT4 receptor in subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None